Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

01-09-2012

Longitudinal changes in social functioning in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II)

Auteurs: Francesco Patti, Maria Pia Amato, Maria Trojano, Stefano Bastianello, Maria Rosalia Tola, Orietta Picconi, Sabina Cilia, Salvatore Cottone, Luigi M. E. Grimaldi

Gepubliceerd in: Quality of Life Research | Uitgave 7/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To report longitudinal changes in and explore the influence of cognition on social functioning in mildly disabled patients with relapsing–remitting multiple sclerosis (RRMS).

Methods

Italian patients (18–50 years) with RRMS and Expanded Disability Status Scale (EDSS) score ≤4.0 were assigned to interferon β-1a, 44 or 22 μg subcutaneously three times weekly, and underwent annual assessments for social functioning (Environmental Status Scale [ESS]) over 3 years.

Results

Baseline total ESS score did not differ between patients with and without cognitive impairment (P = 0.505). Total ESS score remained low (<2.0) and stable over 3 years in the whole study population, but worsened slightly when assessed by assigned treatment or treatment and baseline cognitive status (both P = 0.004), driven mostly by changes in the ‘transportation’ and ‘financial/economic status’ subscales. The strongest independent predictor of worsening ESS score was baseline EDSS score. Test–retest analyses confirmed that total ESS score and most subscales changed little over 3 years.

Conclusion

ESS scores remained low and changed minimally over 3 years, reflecting the mild physical disability and good cognitive performance in this patient population. Determining the influence of cognitive function and treatment on longitudinal changes in social functioning requires further studies.
volgende artikel Measuring fatigue in persons with multiple sclerosis: creating a crosswalk between the Modified Fatigue Impact Scale and the PROMIS Fatigue Short Form
Literatuur
1.
Foley, J. F., & Brandes, D. W. (2009). Redefining functionality and treatment efficacy in multiple sclerosis. Neurology, 72, S1–S11.PubMedCrossRef
2.
Turpin, K. V., Carroll, L. J., Cassidy, J. D., & Hader, W. J. (2007). Deterioration in the health-related quality of life of persons with multiple sclerosis: The possible warning signs. Multiple Sclerosis, 13, 1038–1045.PubMedCrossRef
3.
Rothwell, P. M., McDowell, Z., Wong, C. K., & Dorman, P. J. (1997). Doctors and patients don’t agree: Cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. British Medical Journal, 314, 1580–1583.PubMedCrossRef
4.
Mitchell, A. J., Benito-Leon, J., Gonzalez, J. M., & Rivera-Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. Lancet Neurology, 4, 556–566.PubMedCrossRef
5.
Benito-Leon, J., Morales, J. M., & Rivera-Navarro, J. (2002). Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. European Journal of Neurology, 9, 497–502.PubMedCrossRef
6.
Miller, D. M., Rudick, R. A., Baier, M., Cutter, G., Doughtery, D. S., Weinstock-Guttman, B., et al. (2003). Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 9, 1–5.PubMedCrossRef
7.
Patti, F., Amato, M. P., Trojano, M., Bastianello, S., Tola, M. R., Picconi, O., et al. (2011). Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Multiple Sclerosis, 17, 991–1001.PubMedCrossRef
8.
Hakim, E. A., Bakheit, A. M., Bryant, T. N., Roberts, M. W., Intosh-Michaelis, S. A., Spackman, A. J., et al. (2000). The social impact of multiple sclerosis—A study of 305 patients and their relatives. Disability and Rehabilitation, 22, 288–293.PubMedCrossRef
9.
Ford, H. L., Gerry, E., Johnson, M. H., & Tennant, A. (2001). Health status and quality of life of people with multiple sclerosis. Disability and Rehabilitation, 23, 516–521.PubMedCrossRef
10.
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000). Relapses and progression of disability in multiple sclerosis. New England Journal of Medicine, 343, 1430–1438.PubMedCrossRef
11.
Goretti, B., Ghezzi, A., Portaccio, E., Lori, S., Zipoli, V., Razzolini, L., et al. (2010). Psychosocial issue in children and adolescents with multiple sclerosis. Neurological Sciences, 31, 467–470.PubMedCrossRef
12.
Kotterba, S., Orth, M., Eren, E., Fangerau, T., & Sindern, E. (2003). Assessment of driving performance in patients with relapsing-remitting multiple sclerosis by a driving simulator. European Neurology, 50, 160–164.PubMedCrossRef
13.
Morrow, S. A., Drake, A., Zivadinov, R., Munschauer, F., Weinstock-Guttman, B., & Benedict, R. H. (2010). Predicting loss of employment over three years in multiple sclerosis: Clinically meaningful cognitive decline. The Clinical Neuropsychologist, 24, 1131–1145.PubMedCrossRef
14.
Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology, 41, 692–696.PubMedCrossRef
15.
Amato, M. P., Ponziani, G., Siracusa, G., & Sorbi, S. (2001). Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Archives of Neurology, 58, 1602–1606.PubMedCrossRef
16.
Vanner, E. A., Block, P., Christodoulou, C. C., Horowitz, B. P., & Krupp, L. B. (2008). Pilot study exploring quality of life and barriers to leisure-time physical activity in persons with moderate to severe multiple sclerosis. Disability and Health Journal, 1, 58–65.PubMedCrossRef
17.
Thompson, A. J. (1999). Measuring handicap in multiple sclerosis. Multiple Sclerosis, 5, 260–262.PubMed
18.
Mellerup, E., Fog, T., Raun, N., Colville, P., De Rham, B., Hannah, B., et al. (1981). The socio-economic scale. Acta Neurologica Scandinavica, 64, 130–138.
19.
Stewart, G., Kidd, D., & Thompson, A. J. (1995). The assessment of handicap: An evaluation of the Environmental Status Scale. Disability and Rehabilitation, 17, 312–316.PubMedCrossRef
20.
Fog, T., Heltberg, A., Kyhn, K., Mellerup, E., Raun, N. E., & Zeeberg, I. (1984). Evaluation of disability, incapacity and environmental status scales in multiple sclerosis. Acta Neurologica Scandinavica Supplement, 101, 77–86.
21.
Patti, F., Amato, M., Trojano, M., Bastianello, S., Tola, M., Goretti, B., et al. (2009). Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: Baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Multiple Sclerosis, 15, 779–788.PubMedCrossRef
22.
Patti, F., Amato, M. P., Bastianello, S., Caniatti, L., Di Monte, E., Ferrazza, P., et al. (2010). Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 16, 68–77.PubMedCrossRef
23.
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology, 50, 121–127.PubMedCrossRef
24.
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H. P., Kappos, L., et al. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Annals of Neurology, 58, 840–846.PubMedCrossRef
25.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (4th ed.). Washington DC: American Psychiatric Publishing, Inc.
26.
Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41, 685–691.PubMedCrossRef
27.
Barbarotto, R., Laiacona, M., Frosio, R., Vecchio, M., Farinato, A., & Capitani, E. (1998). A normative study on visual reaction times and two Stroop colour-word tests. Italian Journal of Neurological Sciences, 19, 161–170.PubMedCrossRef
28.
Amato, M. P., Portaccio, E., Goretti, B., Zipoli, V., Ricchiuti, L., De Caro, M. F., et al. (2006). The Rao’s Brief Repeatable Battery and Stroop test: Normative values with age, education and gender corrections in an Italian population. Multiple Sclerosis, 12, 787–793.PubMedCrossRef
29.
Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research, 4, 187–206.PubMedCrossRef
30.
Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.PubMedCrossRef
31.
Colombo, L., Sartori, G., & Brivio, C. (2002). La stima del quoziente intellettivo tramite l’applicazione del TIB (Test di Intelligenza Breve). Giornale Italiano di Psicologia, 3, 613–637.
32.
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994). Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clinical Infectious Diseases, 18(Suppl. 1), S79–S83.PubMedCrossRef
33.
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592.PubMed
34.
Pina Latorre, M. A., Ara, J. R., Modrego, P. J., & Martin, M. (2001). Evaluation of handicap and socio-economic status in patients with multiple sclerosis—Data from a population-based survey in the sanitary area of Calatayud, northern Spain. Wiener Medizinische Wochenschrift, 151, 224–227.PubMed
35.
Amato, M. P., Zipoli, V., Goretti, B., Portaccio, E., De Caro, M. F., Ricchiuti, L., et al. (2006). Benign multiple sclerosis: Cognitive, psychological and social aspects in a clinical cohort. Journal of Neurology, 253, 1054–1059.PubMedCrossRef
36.
Sumowski, J. F., Wylie, G. R., DeLuca, J., & Chiaravalloti, N. (2010). Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: Functional magnetic resonance imaging evidence for cognitive reserve. Brain, 133, 362–374.PubMedCrossRef
37.
Sumowski, J. F., Wylie, G. R., Chiaravalloti, N., & DeLuca, J. (2010). Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis. Neurology, 74, 1942–1945.PubMedCrossRef
38.
Benedict, R. H., Morrow, S. A., Weinstock-Guttman, B., Cookfair, D., & Schretlen, D. J. (2010). Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. Journal of the International Neuropsychological Society, 16, 829–835.PubMedCrossRef
39.
Banati, M., Sandor, J., Mike, A., Illes, E., Bors, L., Feldmann, A., et al. (2010). Social cognition and theory of mind in patients with relapsing-remitting multiple sclerosis. European Journal of Neurology, 17, 426–433.PubMedCrossRef
40.
Patti, F., Amato, M. P., Tola, M. R., Trojano, M., Ferrazza, P., Picconi, O., et al. (2008). Cognitive impairment, social functioning and fatigue in patients with relapsing-remitting multiple sclerosis: The COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Multiple Sclerosis, 14(Suppl. 1), S265.
41.
Patti, F., Pozzilli, C., Montanari, E., Pappalardo, A., Piazza, L., Levi, A., et al. (2007). Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Multiple Sclerosis, 13, 783–791.PubMedCrossRef
42.
Flensner, G., Ek, A. C., Landtblom, A. M., & Soderhamn, O. (2008). Fatigue in relation to perceived health: People with multiple sclerosis compared with people in the general population. Scandinavian Journal of Caring Sciences, 22, 391–400.PubMedCrossRef
43.
Rudick, R. A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P. A., Confavreux, C., et al. (2007). Health-related quality of life in multiple sclerosis: Effects of natalizumab. Annals of Neurology, 62, 335–346.PubMedCrossRef
Metagegevens
Titel
Longitudinal changes in social functioning in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II)
Auteurs
Francesco Patti
Maria Pia Amato
Maria Trojano
Stefano Bastianello
Maria Rosalia Tola
Orietta Picconi
Sabina Cilia
Salvatore Cottone
Luigi M. E. Grimaldi
Publicatiedatum
01-09-2012
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 7/2012
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-0021-6

Andere artikelen Uitgave 7/2012

Relationship between health-related quality of life and clustering of metabolic syndrome diagnostic components

  • Brief Communication

The association between cumulative adversity and mental health: considering dose and primary focus of adversity

The internal responsiveness of the Oral Health Impact Profile-14 to detect differences in clinical parameters related to surgical third molar removal

  • Open Access

Health-related quality of life changes associated with buprenorphine treatment for opioid dependence

Confirmatory factor analysis of the General Health Questionnaire (GHQ-12) in Spanish adolescents

The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy